Located in the Ben Franklin Techventures facility in Bethlehem PA., the platform separation technology developed by Raven Biomaterials is based on a unique solid core of metallic microparticles are described as 50X more magnetic and 4X denser than current alternatives. The firm's material properties - along with surface characteristics, size, and shape enable mixing, dispersion, and separation over larger distances in complex solutions (blood and potentially homogenate) - are also described as * Removing >90 % of Contaminants * Retaining >90% of targeted Cells. The system's core further drives faster processes, improved purity and quality, reducing time and costs. Firm data further notes that RBI Beads can be directly applied to blood samples or Leucopaks
